Bobby Moy MA
Managing Director, Clarion, a Lumanity Company
Robert (Bobby) Moy is a managing director with Clarion. Since joining Clarion in 2004, he has built expertise in a broad range of therapeutic areas and projects—from rare to mass markets and from the earliest stages of product development through launch.
His current areas of focus are in supporting early commercialization decisions for products targeting rare diseases, transplant, and CNS disorders. Bobby also has a strong interest in building strategies around novel therapeutic approaches and mechanisms of action.
Bobby received an MA in Neurobiology from Harvard University and received a BA with dual concentrations in History and Neuroscience from Oberlin College.